Fact CheckerSign in

NCT05572736Completed

Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure

Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure (PhysioSync-HF)

Source: ClinicalTrials.gov · Last updated 8 Jun 2025

Brief summary (registry, in English)

The purpose of this study is to evaluate the efficacy and safety of conduction system pacing versus biventricular pacing in patients with chronic heart failure with reduced ejection fraction and left bundle branch block.

Status (registry)
Completed
Study type
Interventional
Enrollment
179 (actual)
First submitted
2 Sept 2022
Start date
Nov 2022
Primary completion date
Jan 2025
Lead sponsor
Hospital Moinhos de Vento
NCT number
NCT05572736

What you commit to

  • Study type: Interventional
  • Participants enrolled: 179
  • From Nov 2022 to the primary completion date, Jan 2025
  • 14 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Plan to implant an implantable cardioverter defibrillator (ICD), with or without resynchronization therapy (CRT-D)

Other illness

  • Life expectancy \<12 months due to any disease
  • Dementia or advanced cerebrovascular disease
  • Enrollment in other clinical trials involving cardiac pacing

Other

  • NYHA class IV
  • Pregnancy or pre-menopausal women who do not use regular contraceptive methods
  • Patients unable to understand and sign the consent for participation

Who the study is looking for

  • Male or female, age ≥18 years
  • Established diagnosis of symptomatic heart failure (New York Heart Association class II-III)
  • Left ventricular ejection fraction ≤35% in prior 3 months
  • Left bundle branch block (QRS ≥130 ms)
  • Clinical indication for cardiac resynchronization therapy
  • Patients should be clinically stable
  • Patients should receive background standard of care for heart failure with reduced ejection fraction, with the maximum tolerated doses of ACE inhibitor or ARB or ARNI, beta-blocker, and mineralocorticoid receptor antagonist

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (14)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Geral Universitário de Cuiabá
Coordinator of this site? Confirm its status
CuiabáBrazilUnknown status
SOS Cardio
Coordinator of this site? Confirm its status
FlorianópolisBrazilUnknown status
Fundação Hospital do Coração Francisca Mendes
Coordinator of this site? Confirm its status
ManausBrazilUnknown status
Hospital Moinhos de Vento
Coordinator of this site? Confirm its status
Porto AlegreBrazilUnknown status
Hospital Mae de Deus
Coordinator of this site? Confirm its status
Porto AlegreBrazilUnknown status
Hospital de Clinicas de Porto Alegre
Coordinator of this site? Confirm its status
Porto AlegreBrazilUnknown status
Instituto de Medicina Integral Professor Fernando Figueira
Coordinator of this site? Confirm its status
RecifeBrazilUnknown status
Instituto Nacional de Cardiologia
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status
Hospital Ana Nery
Coordinator of this site? Confirm its status
SalvadorBrazilUnknown status
Instituto de Cardiologia de Santa Catarina
Coordinator of this site? Confirm its status
São JoséBrazilUnknown status
Beneficência Portuguesa
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
Hospital Alemão Oswaldo Cruz
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
Hospital Universitário da Universidade Federal do Piauí
Coordinator of this site? Confirm its status
TeresinaBrazilUnknown status
Hospital Universitário Cassiano Antônio de Moraes
Coordinator of this site? Confirm its status
VitóriaBrazilUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.